Hurry Up and Wait: Is Accelerated Approval of New Cancer Drugs in the Best Interests of Cancer Patients?-Reference-Cited by-同舟云学术

Hurry Up and Wait: Is Accelerated Approval of New Cancer Drugs in the Best Interests of Cancer Patients?

Published:2003-10-15 Issue:20 Volume:21 Page:3718-3720
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Schilsky Richard L.¹

Affiliation:

1. University of Chicago, Chicago, IL

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.07.942

Reference18 articles.

1. End Points and United States Food and Drug Administration Approval of Oncology Drugs

2. Hirschfeld S, Nagamura F, Keegan P: Food and Drug Administration with the accelerated approval program for oncology drugs. Proc Am Soc Clin Oncol 22:520,2003, (abstr 2094)

3. New Guidelines to Evaluate the Response to Treatment in Solid Tumors

4. Hillman SL, Sargent DJ, An M-W, et al: Evaluation of RECIST criteria in determining the response to treatment in solid tumors: A North Central Cancer Treatment Group investigation. Proc Am Soc Clin Oncol 22:521,2003, (abstr 2095)

5. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness;Frontiers in Medicine;2022-02-03

2. Early market access of cancer drugs in the EU;Annals of Oncology;2016-01

3. Accelerated Approval;Methods and Applications of Statistics in Clinical Trials;2014-09-26

4. Critical review of ‘Public domain application’: a flexible drug approval system in Japan;Annals of Oncology;2013-05

5. Accelerated Approval of Cancer Drugs: Improved Access to Therapeutic Breakthroughs or Early Release of Unsafe and Ineffective Drugs?;Journal of Clinical Oncology;2009-09-10